S&P 500 2,441.20 17.28
Gold$1,224.80 $5.30
Nasdaq 6,253.81 61.92
Crude Oil $60,490.00      $-1570.00
Market Update

Ascena Agrees to Acquire Ann, Endo to Buy Par for $8 B


Author: Mukesh Buch
ticker.com
Last Update: 11:55 AM ET May 18 2015

11:45 AM New York Ascena Retail agreed to acquire apparel retailer Ann for $2 billion. Par Pharmaceutical agreed to be acquire by U.K.-based Endo International for $8 billion. Elbit Systems net declined 8% but revenues jumped 4%. Kite Pharma net loss widened. W.P. Carey net tumbled 69%.

Tollbooth Index slipped 0.3% or 28.83 to 10,749.50.

Earnings Review

Ascena Retail Group Inc (ASNA) jumped 2.9% or 42 cents to $14.63 after the specialty retailer agreed to acquire women''s apparel retailer Ann, Inc for about $2 billion in cash and stock, a 21.4% premium over the closing price of Ann on May 15.

Under terms, Shareholder of Ann will receive $37.34 in cash and 0.68 of Ascena shares.

The transaction is expected to close in the second-half.

Shares of Ann, Inc surged 20% to $46.45.

Par Pharmaceutical Companies, Inc, the generics drugs-maker agreed to be acquire by the U.K.-based privately held and specialty healthcare solution provider Endo International Plc for $8.05 billion in cash and shares from private investment firm TPG Capital, L.P.

The transaction is expected to close in the second-half of this year.

Elbit Systems Ltd (ESLT) slumped 2.1% or $1.70 to $77.69 after the Israel-based defense electronics products provider reported revenues in the first-quarter ending in March jumped 3.5% to $706.6 million from a year ago period.

Net income in the quarter declined 7.5% to $44.6 million or $1.04 per diluted share compared to $48.2 million or $1.13 from the same quarter last year.

JD.Com Inc (JD) climbed 2.1% or 67 cents to $34.10 after the China-based online market place agreed to acquire 10% stake in Chinese software firm Kingdee International Software Group for about $171 million or HK$1.3 billion.

The transaction is expected to close in the second-quarter of this year.

Kite Pharma Inc (KITE) plunged 7.4% or $3.71 to $46.31 after the clinical-stage biopharmaceutical company said revenues in the first-quarter ending in March was $2.9 million from a year ago period.

Net loss in the quarter widened to $15.1 million or 36 cents per diluted share compared to $3.7 million or 66 cents from the same quarter last year.

W.P. Carey Inc (WPC) fell 31 cents to $64.42 after the real estate developer said total revenues in the first-quarter ending in March slipped 1.6% to $204.8 million from a year ago period.

Net income in the quarter tumbled 68.7% to $36.1 million or 34 cents per diluted share compared to $115.5 million or $1.27 from the same quarter last year.

  1
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites. Market data: BATS Exchange. Inc